Matinas biopharma to webcast conference call discussing second quarter 2022 financial and operational results on august 11, 2022

Bedminster, n.j., july 28, 2022 (globe newswire) -- matinas biopharma holdings, inc. (nyse amer: mtnb), a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (lnc) platform technology, today announced the company will host a conference call and live audio webcast on thursday, august 11, 2022 at 8:30 a.m. et to discuss operational and financial results for the second quarter ended june 30, 2022.
MTNB Ratings Summary
MTNB Quant Ranking